CLINICAL RESEARCH: CARDIAC IMAGING
Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy
Marly Conceição Silva, MD*,
Zilda Maria Alves Meira, MD, PhD ,
Juliana Gurgel Giannetti, MD, PhD,
Marcelo Moreira da Silva,
Alysson Félix Oliveira Campos, RT*,
Márcia de Melo Barbosa, MD, PhD*,
Geraldo Moll Starling Filho, MD*,
Rogério de Aguiar Ferreira, MD*,
Mayana Zatz, PhD and
Carlos Eduardo Rochitte, MD, PhD*, ,*
* Axial Centro de Imagem, Belo Horizonte, Minas Gerais, Brazil
Federal University of Minas Gerais Medical School, Minas Gerais, Brazil
Human Genome Research Center, Biosciences Institute, University of São Paulo, São Paulo, Brazil
Heart Institute (InCor) University of São Paulo Medical School, São Paulo, Brazil.
Manuscript received May 22, 2006;
revised manuscript received September 21, 2006,
accepted October 16, 2006.
* Reprint requests and correspondence: Dr. Carlos E. Rochitte, Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Setor de Ressonância Magnética e Tomografia Cardiovascular, Avenida Dr. Enéas de Carvalho Aguiar, 44, Andar AB, Cerqueira César, São Paulo, SP, Brazil 05403-000. (Email: rochitte{at}incor.usp).
Objectives: This study sought to analyze whether cardiovascular magnetic resonance (CMR) can detect and quantify myocardial damage in the early stages of cardiomyopathy in muscular dystrophies (MD).
Background: Muscular dystrophy is a genetic disease that involves skeletal and cardiac tissues of humans. Cardiomyopathy is common, and death secondary to cardiac or respiratory diseases occurs early in life. Cardiovascular magnetic resonance is a reliable method for assessing global and regional cardiac function, allowing also for the detection of myocardial fibrosis (MF).
Methods: Ten patients with Duchenne or Becker dystrophies were studied by CMR. Physical examination, Chagas disease serological tests, electrocardiogram, chest radiograph, total creatine kinase, and Doppler echocardiogram were also obtained in all patients.
Results: Patients with MF had a lower ejection fraction than those without. Myocardial fibrosis (midwall and/or subepicardial) was observed in 7 of the 10 patients, and the lateral wall was the most commonly involved segment. There was moderate correlation between segmental MF and dysfunction.
Conclusions: Cardiovascular magnetic resonance can identify MF and may be useful for detecting the early stages of cardiomyopathy in MD. Future work will be needed to evaluate whether CMR can influence cardiomyopathy and outcomes.
|
Abbreviations and Acronyms
| | CK = creatine kinase | | CMR = cardiovascular magnetic resonance | | LV = left ventricle/ventricular | | LVEF = left ventricular ejection fraction | | MD = muscular dystrophy | | MDE = myocardial delayed enhancement | | MF = myocardial fibrosis | | RV = right ventricle/ventricular |
|
This article has been cited by other articles:
|
|
|
|
 
A. Yilmaz and U. Sechtem
Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy
Heart,
March 1, 2012;
98(5):
420 - 429.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Verhaert, K. Richards, J. A. Rafael-Fortney, and S. V. Raman
Cardiac Involvement in Patients With Muscular Dystrophies: Magnetic Resonance Imaging Phenotype and Genotypic Considerations
Circ Cardiovasc Imaging,
January 1, 2011;
4(1):
67 - 76.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Kimura, Y. Matsuo, T. Nakajima, T. Nishikawa, S. Kawamura, S. Sannohe, N. Hagiwara, and F. Sakai
Myocardial Fat at Cardiac Imaging: How Can We Differentiate Pathologic from Physiologic Fatty Infiltration?
RadioGraphics,
October 1, 2010;
30(6):
1587 - 1602.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mavrogeni and A. Papavasiliou
Response
Chest,
September 1, 2010;
138(3):
757 - 757.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alpendurada, J. Wong, and D. J. Pennell
Practical applications of cardiovascular magnetic resonance
Heart Asia,
July 5, 2010;
1(1):
31 - 37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ishizu, Y. Seo, Y. Enomoto, H. Sugimori, M. Yamamoto, T. Machino, R. Kawamura, and K. Aonuma
Experimental validation of left ventricular transmural strain gradient with echocardiographic two-dimensional speckle tracking imaging
Eur Heart J Cardiovasc Imaging,
May 1, 2010;
11(4):
377 - 385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Yilmaz, H.-J. Gdynia, A. C. Ludolph, K. Klingel, R. Kandolf, and U. Sechtem
Cardiomyopathy in a Duchenne Muscular Dystrophy Carrier and Her Diseased Son: Similar Pattern Revealed by Cardiovascular MRI
Circulation,
March 16, 2010;
121(10):
e237 - e239.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Myerson, J. Francis, and S. Neubauer
Muscular dystrophies
OSH Cardiovascular Magnetic Resonance,
January 1, 2010;
1(1):
med-9780199549573-div1-08 - med-9780199549573-div1-08.
[Full Text]
|
|
|
|
|
|
|
H. Baccouche, H. Mahrholdt, G. Meinhardt, R. Merher, M. Voehringer, S. Hill, K. Klingel, R. Kandolf, U. Sechtem, and A. Yilmaz
Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease
Eur. Heart J.,
December 1, 2009;
30(23):
2869 - 2879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. N. Hor, J. Wansapura, L. W. Markham, W. Mazur, L. H. Cripe, R. Fleck, D. W. Benson, and W. M. Gottliebson
Circumferential Strain Analysis Identifies Strata of Cardiomyopathy in Duchenne Muscular Dystrophy: A Cardiac Magnetic Resonance Tagging Study
J. Am. Coll. Cardiol.,
April 7, 2009;
53(14):
1204 - 1210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W P Bandettini and A E Arai
Advances in clinical applications of cardiovascular magnetic resonance imaging
Heart,
November 1, 2008;
94(11):
1485 - 1495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M McNally
Duchenne muscular dystrophy: how bad is the heart?
Heart,
August 1, 2008;
94(8):
976 - 977.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Giglio, G. Camastra, and G. Ansalone
Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
2019 - 2020.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Silva, Z. M. A. Meira, J. Gurgel Giannetti, M. Zatz, and C. E. Rochitte
Reply
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
2020 - 2020.
[Full Text]
[PDF]
|
|
|
|
